MP
MSAC

Mangrove Partners’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Mangrove Partners’s Portfolio MSAC Stock Details MSAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,260
Closed -$237K – 593
2021
Q3 		$237K Sell
24,260
-73,640
-75% -$709K 0.02% 343
2021
Q2 		$945K Buy
+97,900
New +$957K 0.1% 251

Other funds holding MSAC

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Mangrove Partners's MSAC Position: Q4 2021 in Review

Mangrove Partners sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q4 2021, closing a stake of 24,260 shares — an estimated $237K sold.

Mangrove Partners first reported a position in MSAC in Q2 2021 and held it in 2 quarters. The position peaked at $945K in Q2 2021. 55 funds tracked by Wall St. Rank hold MSAC as of Q4 2021.

  • Mangrove Partners reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q4 2021 after selling out during the quarter.
  • Mangrove Partners sold 24,260 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q4 2021, an estimated $237K.
  • Mangrove Partners first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 2 quarters.
  • Mangrove Partners's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $945K in Q2 2021.
  • 55 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q4 2021.

Based on Mangrove Partners's 13F filing for Q4 2021, filed 14 Feb 2022.